Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras
暂无分享,去创建一个
A. Eggermont | B. van Etten | T. Huet | A M M Eggermont | T Huet | B van Etten | T L M ten Hagen | M R de Vries | G Ambagtsheer | G. Ambagtsheer | M. D. de Vries | T. L. T. ten Hagen
[1] K. Hughes. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. , 1988, Surgery.
[2] Y. Vergouwe,et al. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration , 1998, Gene Therapy.
[3] D. Fraker,et al. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] I. B. Borel Rinkes,et al. Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion. , 1997, British Journal of Cancer.
[5] Peter Schlag,et al. Resection of the liver for colorectal carcinoma metastases , 1988, Diseases of the colon and rectum.
[6] Hanns Lochmüller,et al. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. , 1995, Gene therapy.
[7] D. Spandidos,et al. Ras oncogene activation in benign and malignant colorectal tumours. , 1995, Tumori.
[8] A. Eggermont,et al. Isolated Limb Perfusion for Local Gene Delivery: Efficient and Targeted Adenovirus-Mediated Gene Transfer Into Soft Tissue Sarcomas , 2000, Annals of surgery.
[9] O. Cochet,et al. Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: a novel approach for cancer therapy? , 1999, Cancer detection and prevention.
[10] D. Ilstrup,et al. Resection of hepatic metastases from colorectal cancer. , 1984, Archives of surgery.
[11] L H Blumgart,et al. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. , 1976, Clinical oncology.
[12] C. V. D. van de Velde,et al. Towards gene therapy for colorectal liver metastases. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[13] S. Shirasawa,et al. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. , 1993, Science.
[14] N. J. McNally,et al. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). , 1998, British Journal of Cancer.
[15] A. Eggermont,et al. Adenovirus-mediated interleukin 3 beta gene transfer by isolated limb perfusion inhibits growth of limb sarcoma in rats. , 2001, Human gene therapy.
[16] J. Folkman,et al. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[17] D. Chung,et al. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. , 2001, Cancer research.
[18] P. Delrio,et al. The First Breast Cancer Screening Program in Southern Italy: Preliminary Results from Three Municipalities of the Naples Province , 1995, Tumori.
[19] J. Roth,et al. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. , 1991, Cancer research.
[20] A. Marinelli,et al. Isolated-organ perfusion for local gene delivery: efficient adenovirus-mediated gene transfer into the liver , 1997, Gene Therapy.
[21] J. Roth,et al. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct. , 1993, Cancer research.
[22] P. Kuppen,et al. A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in rats. , 1990, British Journal of Cancer.
[23] J. Jeekel,et al. Interferon treatment of a transplantable rat colon adenocarcinoma: Importance of tumor site , 1984, International journal of cancer.
[24] O. Cochet,et al. Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression. , 1998, Cancer research.
[25] R. Livingston,et al. Principles of cancer treatment , 1982 .
[26] P Ghazal,et al. Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Kerbel,et al. Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[28] T. Ravikumar,et al. Resection of hepatic metastases from colorectal cancer. Biologic perspective. , 1989, Annals of surgery.
[29] M. Miyazaki,et al. Enhancement of cytotoxicity of doxorubicin by verapamil in the hepatic artery infusion for liver tumors in rats , 1993, Cancer.
[30] L. Ellis,et al. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. , 1998, Cancer research.
[31] G. Stuhldreier,et al. Continuous or bolus chemotherapy with 5-fluoro-2′-deoxyuridine in transplanted experimental liver tumors? , 2004, Journal of Cancer Research and Clinical Oncology.
[32] D. Scudiero,et al. New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.
[33] A. Eggermont,et al. Tumor Necrosis Factor-&agr; Augments Tumor Effects in Isolated Hepatic Perfusion With Melphalan in a Rat Sarcoma Model , 2000, Journal of immunotherapy.
[34] R. Prehn,et al. Immunity to methylcholanthrene-induced sarcomas. , 1957, Journal of the National Cancer Institute.
[35] I. B. Borel Rinkes,et al. Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: experimental studies in pigs and phase I data from humans. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[36] P. Kuppen,et al. Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion. , 1991, British Journal of Cancer.
[37] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[38] J. Prieto,et al. A blood–tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds , 2000, Gene Therapy.
[39] E. Scolnick,et al. Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family , 1982, Journal of virology.